Lean mass
Increase · moderate
Myostatin inhibition
Literature evidence
Compound library
Vivy evidence dossier
Follistatin 344
Also indexed as Follistatin, FST 344
T3Peptides
Read this entry as context, not instruction.
Evidence labels describe the material available in this reference entry. They do not establish that a compound is appropriate, effective, or safe for you. Inclusion is not a recommendation to use it.
Reference context
Pharmacokinetic context
Half-life1.0 days
This field summarizes the library record. Half-life can vary with formulation, indication, and individual clinical context.
Observed relationships
Biomarker context
IGF-1
Increase · small
Muscle growth signaling
Literature evidence
FSH
Decrease · small
Activin binding reduces FSH
Literature evidence
LH
Modulate · small
Pituitary feedback
Literature evidence
Keep in view
Safety discussion points
Follistatin 344 is a myostatin inhibitor that binds and neutralizes myostatin, promoting muscle growth. Investigational. Not FDA-approved.
Keep the reference close
Track Follistatin 344 in context.
Hey Vivy helps you organize protocols and review change over time. It does not diagnose, prescribe, or replace qualified care.